Skip to search formSkip to main contentSkip to account menu

E 3810

Known as: E-3810, E3810 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

rabeprazole

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Plasma direct injection high-performance liquid chromatographic method for simultaneously determining E3810 enantiomers and their metabolites by using flavoprotein-conjugated column.
A high-performance liquid chromatographic method using the column-switching technique was developed for the simultaneous… 
1996
1996
Mechanism of inhibition of H+, K(+)-ATPase by sodium 2-[[4-(3- methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole (E3810).
Sodium 2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl ]- 1H-benzimidazole (E3810) and omeprazole inhibit gastric… 
1996
1996
Oligomeric Regulation of Gastric H,K-ATPase (*)
The H,K-ATPase of intact gastric vesicles has two K values for ATP hydrolysis, 7 and 80 μM. Irradiation of vesicles with… 
1995
1995
A proton pump inhibitor, E3810, has antibacterial activity through binding to Helicobacter pylori.
1995
1995
A proton pump inhibitor, E3810, has antibacterial activity through binding toHelicobacter pylori
Helicobacter pylori infection is causally related to atrophic gastritis, and it may also be associated with peptic ulcer and… 
1994
1994
Specific proton pump inhibitors E3810 and lansoprazole affect the recovery process of gastric secretion in rats differently.
1994
1994
Determination of a new H(+)-K+ ATPase inhibitor (E3810) and its four metabolites in human plasma by high-performance liquid chromatography.
1993
1993
Different biochemical modes of action of two irreversible H+,K(+)-ATPase inhibitors, omeprazole and E3810.
Omeprazole and E3810 were found to inhibit gastric H+,K(+)-ATPase following different biochemical mechanisms. Effects of the… 
1993
1993
[Inhibitory action of E3810 on H+,K(+)-ATPase and gastric acid secretion in vitro].
The inhibitory action of (+-)-sodium 2-[(4-(3-methoxypropoxy)-3-methylpyridine-2-yl) methylsulfinyl]-1H- benzimidazole (E3810) on… 
1991
1991
Effects of the Proton Pump Inhibitor, E3810, on Gastric Secretion and Gastric and Duodenal Ulcers or Erosions in Rats
SummaryThe effects of E3810, a potent proton pump inhibitor, on gastric secretion and gastric or duodenal ulcers or erosions were… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)